121 related articles for article (PubMed ID: 19919613)
21. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment.
Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
[TBL] [Abstract][Full Text] [Related]
23. Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon.
Halmos O; Inturri P; Galligioni A; Di Landro D; Rigotti P; Tedeschi U; Graziotto A; Burra P; Poletti A; Rossaro L
Clin Transplant; 1996 Aug; 10(4):374-8. PubMed ID: 8884111
[TBL] [Abstract][Full Text] [Related]
24. Visceral Kaposi's sarcoma remission after intestinal transplant. First case report and systematic literature review.
D'Amico F; Fuxman C; Nachman F; Bitetti L; Fauda M; Echevarria C; Solar H; Politi P; Cabanne A; Mauriño E; Ruf A; Gondolesi GE
Transplantation; 2010 Sep; 90(5):547-54. PubMed ID: 20625354
[TBL] [Abstract][Full Text] [Related]
25. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
26. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
27. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
28. [A case of Kaposi's sarcoma in the rapamycin era].
Gemelli A; Paciolla A; Oliosi F; Basso A; Moscardin R; Tineo MC; Romano P; Alaibac M; Aversa S; Furian L; D'Angelo A; Bonfante L
G Ital Nefrol; 2009; 26(1):90-3. PubMed ID: 19255968
[TBL] [Abstract][Full Text] [Related]
29. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2.
Chen SJ; Nakahara T; Takahara M; Kido M; Dugu L; Uchi H; Takeuchi S; Tu YT; Moroi Y; Furue M
Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus (rapamycin): from the soil of Easter Island to a bright future.
Paghdal KV; Schwartz RA
J Am Acad Dermatol; 2007 Dec; 57(6):1046-50. PubMed ID: 17583372
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.
Farge D
Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
33. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
[TBL] [Abstract][Full Text] [Related]
34. Posttransplant Kaposi's sarcoma restricted to the site of a previous deep venous thrombosis: abrupt onset after withdrawal of sirolimus.
González-López MA; Rodrigo E; González-Vela MC; Fernández-Llaca H; Arias-Rodríguez MA; Val-Bernal JF
Dermatology; 2006; 213(1):30-3. PubMed ID: 16778423
[TBL] [Abstract][Full Text] [Related]
35. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.
Boratyńska M; Zmonarski SC; Klinger M
Int Immunopharmacol; 2006 Dec; 6(13-14):2018-22. PubMed ID: 17161356
[TBL] [Abstract][Full Text] [Related]
36. Sirolimus monotherapy in liver transplantation.
Di Benedetto F; Di Sandro S; De Ruvo N; Masetti M; Montalti R; Romano A; Guerrini GP; Ballarin R; De Blasiis MG; Gerunda GE
Transplant Proc; 2007; 39(6):1930-2. PubMed ID: 17692656
[TBL] [Abstract][Full Text] [Related]
37. Classic Kaposi's sarcoma treated with topical rapamycin.
Díaz-Ley B; Grillo E; Ríos-Buceta L; Paoli J; Moreno C; Vano-Galván S; Jaén-Olasolo P
Dermatol Ther; 2015; 28(1):40-3. PubMed ID: 25314592
[TBL] [Abstract][Full Text] [Related]
38. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma after renal transplantation.
Kanitakis J
N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
[No Abstract] [Full Text] [Related]
40. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP
Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
